PR
| Q2/17-Q1/18 | Q3/16-Q2/17 | Q4/15-Q3/16 | Q1/15-Q4/15 | Q4/14-Q3/15 | Q2/14-Q1/15 | Q1/14-Q4/14 | Q4/13-Q3/14 | |
| Central Line-Associated B...Central Line-Associated B... | N/A | N/A | N/A | N/A | 0.41 ratio | 0.45 ratio | 0.56 ratio | 0.64 ratio |
| Catheter Associated Urina...Catheter Associated Urina... | N/A | N/A | N/A | N/A | 0.44 ratio | 0.53 ratio | 0.53 ratio | 0.59 ratio |
| Surgical Site Infection f...Surgical Site Infection f... | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Surgical Site Infection f...Surgical Site Infection f... | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Methicillin-resistant Sta...Methicillin-resistant Sta... | 0.46 ratio | 0.35 ratio | 0.64 ratio | 0.70 ratio | 0.52 ratio | 0.46 ratio | 0.32 ratio | 0.19 ratio |
| Clostridium difficile (or...Clostridium difficile (or... | 0.38 ratio | 0.41 ratio | 0.39 ratio | 0.45 ratio | 0.37 ratio | 0.34 ratio | 0.32 ratio | 0.26 ratio |